Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026)
Zevra Therapeutics (ZVRA) reported Inventory Average of $2.0 million for Q1 2026, down 10.58% on a YoY basis from $2.3 million in Q1 2025, and up 30.35% quarter-over-quarter from $1.6 million in Q4 2025.
Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026) Analysis & Trends
Zevra Therapeutics has reported Inventory Average for 2 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average fell 10.58% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 10.58% YoY), and the FY2025 full-year result was $1.9 million, changed N/A from the prior year.
- Inventory Average for Q1 2026 stood at $2.0 million, up from $1.6 million in the prior quarter.
- The five-year high for Inventory Average was $2.3 million in Q1 2025, with the low at $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Zevra Therapeutics | 704.96 Mn | 504.34 Mn | 34.30 Mn | 2.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 2.26 Mn |